We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. District Court for the Eastern District of Pennsylvania dismissed the case “with prejudice,” meaning that the court intends for the dismissal to be final in all courts. Read More
Teva Pharmaceuticals has sued Amicus Therapeutics, alleging the company refused to supply samples of its high-priced branded drug, Galafold (migalastat), as required under federal law. Read More
Rounding out its holdings in the diabetes space, Eli Lilly has bought the remaining shares of biotech Protomer Technologies, which has a peptide- and protein-engineering platform that can identify and synthesize molecules that sense glucose. Read More
The investigational antibody is for treatment of transthyretin amyloidosis, a rare, progressive, fatal disease characterized by amyloid deposits in the heart and peripheral nerve tissue. Read More
Novo Nordisk is exploring beyond its well-paved diabetes track, acquiring its first investigational neurological compound, PRX004, from Prothena in a deal potentially worth up to $1.2 billion. Read More